Navigation Links
Globus Medical Announces Record 2nd Quarter 2007 Results
Date:8/27/2007

AUDUBON, Pa., Aug. 27 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced record revenue for the quarter ending June 30, 2007. The company recorded revenues of $30.2 million for the second quarter -- an increase of 52% over the $19.9 million it achieved in the same quarter a year ago. The announcement follows on the heels of $110 million in series E financing to fund Globus' continued rapid growth.

"The record results were driven by a major expansion of the company's sales and distribution footprint, and the introduction of several new products across its fusion, MIS and biomaterials portfolio," said Rick Kienzle, Executive Vice President of Sales and Marketing, Globus Medical. "In addition, strong market acceptance of our Revere(TM) pedicle screw system continues to fuel significant conversions in our established and new markets."

During the second quarter, Globus Medical added several highly-experienced sales professionals in key U.S. markets, bringing the total number of people added to its sales and distribution infrastructure in 2007 to 25.

So far in 2007, Globus has introduced six new systems that represent significant technological advancements in fusion, MIS and biomaterials. Additionally, in the area of motion preservation, the company announced two "world's first" surgeries using its transforaminal and posterior disc replacement systems.

Globus Medical also entered the biomaterial segment during the second quarter with the introduction of the NuBone(TM) Osteoinductive Bone Graft Product Line, the first of several new biomaterial initiatives planned for the next 12 months. The launch of Globus Medical's MARS(TM) Minimally Invasive Retractor System filled out its MIS product portfolio, further securing the company's leadership position in MIS technology and products. Both MIS and biomaterials are key initiatives in Globus Medical's strategy to innovate acros
'/>"/>

SOURCE Globus Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...all/ -- Bioheart, Inc. (Nasdaq:,BHRT) a biotechnol...autologous (patient-derived) cell therapies and de... damage, today announced it has been added to the,...t Group reconstituted its,comprehensive set of U.S...cording to the Russell Investment Group, the Russe...
(Date:7/2/2008)...rma, a leading provider of,knowledge management so...e,industry, announced today that the Aureus Pharma...ber 23rd and 24th., This symposium follows last y...attended by many of Aureus, pharmaceutical and bio... The symposium included presentations,from industr...
(Date:7/2/2008).../ -- Research conducted at The,Walter and Eliza Ha...to a,major licensing agreement signed between Aust... and Germany-based pharmaceutical company, Merck,S...ment, Merck Serono will seek,to develop new treatm...une,conditions. These prospective treatments will ...
(Date:7/1/2008)...stCall/ -- Schering-Plough,Corporation (NYSE: SGP...reviously announced transaction with Virbac, S.A. ...nchises. These divestments were requested by the,E...arance of the,acquisition of Organon BioSciences N... endocrine, mastitis and,sulphonamide franchises o...
Breaking Biology Technology:Bioheart, Inc., Added to Russell Microcap Index 2Aureus Pharma Announces Date of 2008 Annual User Symposium 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
...nal , a Wisconsin-based pharmaceutical firm, repor...eing a 103 percent increase in sales and raising t... , ,BoneCare,s fourth-quarter net income has been ...and twice the last quarter,s first-ever profit of ...rter from $7.3 million to $14.7 million, bringing ...
...o a new product, behave just like parents jumping ...ical hoopla of the incubation wing is often replac...omes a subdued Dilbertish style revolution. Object... sharp yet harmless, foamy projectiles. Everyone s...tioned. Everyone wants a successful launch. There ...
... Wisconsin, which means the golfing world will bea...orsteps, the 7,514-yard Whistling Straits course i...nd, Cliff Hanger and Voyageur, it,s an inspiring p...sin boasts another course, equally impressive, tha... visitors who might be tempted to return another d...
...for search term "Disney" MADISON NameProtect Inc....gence company, has released the results of an anal...extual advertisements within standard search engin...tings at search engines Google and Yahoo! for ...party advertising on these trademarked terms, with...
Other Biology Technology:BoneCare doubles options and profits as fiscal year closes 2Naming that thing... again? 2Naming that thing... again? 3Naming that thing... again? 4Above par: Playing 18 holes on Wisconsin's high-tech course 2Above par: Playing 18 holes on Wisconsin's high-tech course 3NameProtect study shows 92% of top brands losing out on search engines 2NameProtect study shows 92% of top brands losing out on search engines 3
(Date:7/2/2008)...NUT CREEK, CAIn the continuing effort to tap the v...nd plant domains for bioenergy and environmental a...GI) has announced its latest portfolio of DNA sequ...ng year. The 44 projects, culled from nearly 150 p... Program (CSP), represent over 60 billion nucleoti...
(Date:7/2/2008)...nd Forks, North Dakota, July 2, 2008 Volunteers r...ion International (JDRF), the American Diabetes As...rd (NIHB) will present Senator Byron Dorgan with t...dership on extending the Special Diabetes Program ...:30 a.m. in the Buchli Room at the Hilton Garden I...
(Date:7/2/2008)...h the goal of developing an accurate, powerful and...ngth, scientists of the ETH Zurich Departments of ...ience teamed up with supercomputing experts at IBM...ethod developed by the team combines density measu...the inner-bone microstructure. , Using large-sc...
(Date:7/2/2008)...LD SPRING HARBOR, N.Y. (Tuesday, July 1, 2008) ...ts with the International Haplotype Map Project ha...a tool that displays common patterns of genetic va...e for unrestricted public use from the project,s w... browse the map can be difficult to master for the...
Breaking Biology News(10 mins):US Department of Energy Joint Genome Institute announces new genome sequencing projects 2US Department of Energy Joint Genome Institute announces new genome sequencing projects 3US Department of Energy Joint Genome Institute announces new genome sequencing projects 4US Department of Energy Joint Genome Institute announces new genome sequencing projects 5US Department of Energy Joint Genome Institute announces new genome sequencing projects 6US Department of Energy Joint Genome Institute announces new genome sequencing projects 7Sen. Byron Dorgan to be honored 2ETH Zurich and IBM improve diagnosis of osteoporosis 2HapMap browsing and DDDP methods for genetic analysis featured in CSH Protocols 2Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 1Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 2Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 3Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 4Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 5Greetings From Menopauseland 16173 1Greetings From Menopauseland 16173 2Greetings From Menopauseland 16173 3Journey Lite of Thousand Oaks Announces Special Spring Price Discount In Response to Effects of Softening Economy on Patients Pocketbooks 16170 1Journey Lite of Thousand Oaks Announces Special Spring Price Discount In Response to Effects of Softening Economy on Patients Pocketbooks 16170 2Martek Announces Final Judgment and Order of Dismissal in Class Action 4443 1Martek Announces Final Judgment and Order of Dismissal in Class Action 4443 2
...l surface proteins that generate the strongest imm...y of Chicago have created a vaccine that significa...ase-causing, drug-resistant strains of Staphylococ...ired infections and a rapidly spreading source of ...cted mice against potentially lethal infections wi...
... normal food intake and metabolism, exerts a stron...gion as well as in the hypothalamus, according to ...ding that metabolic hormones directly regulate the... profound implications for how researchers view th...said the senior author, Ralph DiLeone, assistant p...
...that used thermal imaging technology for the first...ned the conventional wisdom that women become arou...Comparing sexual arousal between men and women, we...time it takes healthy young men and women to reach...fessor and founder and director of the Sex and Cou...
... of Wisconsin-Madison School of Medicine and Publi...ted mechanism that governs the formation of blood ... halt tumor growth in cancer patients, says Emery ...sor of pharmacology and member of the UW-Madison P...he research, published in the Journal of Cell Biol...
Other Biology News:MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3Thermal imaging shatters arousal gender gap myth 2New angiogenesis finding may help fight cancer growth 2New angiogenesis finding may help fight cancer growth 3New angiogenesis finding may help fight cancer growth 4
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236
TNR-R2
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
Biology Products: